Re: RESVERLOGIX CORP.CODE OF BUSINESS CONDUCT AND ETHICS
|
2
|
Resverlogix Corp.
|
Sep 12, 2019 03:42PM
|
Re: RESVERLOGIX CORP WTS 2021
|
3
|
Resverlogix Corp.
|
May 11, 2021 04:42PM
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
4
|
Resverlogix Corp.
|
Oct 05, 2020 08:51PM
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 09:07AM
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 03:01PM
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 04:04PM
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 31, 2020 02:46AM
|
Re: Resverlogix Announces Loan Reduction and Extension
|
3
|
Resverlogix Corp.
|
Aug 02, 2019 12:22PM
|
Re: Resverlogix Announces Closing of $15 Million Offering
|
4
|
Resverlogix Corp.
|
Jun 07, 2019 09:22AM
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
3
|
Resverlogix Corp.
|
Mar 14, 2021 02:27PM
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
2
|
Resverlogix Corp.
|
Mar 14, 2021 06:05PM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
11
|
Resverlogix Corp.
|
Dec 22, 2020 09:02AM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 09:35AM
|
Re: Resverlogix Announces $13 Million Private Placement
|
6
|
Resverlogix Corp.
|
Oct 06, 2020 12:42PM
|
Re: Resverlogix Announces $13 Million Private Placement
|
1
|
Resverlogix Corp.
|
Oct 06, 2020 08:30PM
|
Re: Resverlogix Announces $13 Million Private Placement
|
4
|
Resverlogix Corp.
|
Oct 07, 2020 12:23PM
|
Re: Resverlogix and Zenith AGMs.
|
4
|
Resverlogix Corp.
|
Oct 08, 2020 01:36AM
|
Re: Restricted Share Units - approx. 5 million
|
7
|
Resverlogix Corp.
|
Jul 07, 2020 11:39AM
|
Re: Restricted Share Units - approx. 5 million
|
3
|
Resverlogix Corp.
|
Jul 07, 2020 02:39PM
|
Re: Restricted Share Units - approx. 5 million
|
3
|
Resverlogix Corp.
|
Jul 07, 2020 02:43PM
|